Advertisement
Canada markets close in 3 hours 29 minutes

  • S&P/TSX

    21,985.34
    +99.96 (+0.46%)
     

  • S&P 500

    5,103.73
    +55.31 (+1.10%)
     

  • DOW

    38,253.43
    +167.63 (+0.44%)
     

  • CAD/USD

    0.7314
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    84.08
    +0.51 (+0.61%)
     

  • Bitcoin CAD

    87,116.38
    -612.52 (-0.70%)
     

  • CMC Crypto 200

    1,321.75
    -74.78 (-5.35%)
     

  • GOLD FUTURES

    2,348.70
    +6.20 (+0.26%)
     

  • RUSSELL 2000

    1,999.86
    +18.75 (+0.95%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,928.01
    +316.25 (+2.03%)
     

  • VOLATILITY

    15.26
    -0.11 (-0.72%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6836
    +0.0015 (+0.22%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know

Zacks Equity Research

Cronos Group (CRON) closed at $7.29 in the latest trading session, marking a +1.11% move from the prior day. This change outpaced the S&P 500's 0.47% gain on the day. Meanwhile, the Dow gained 0.4%, and the Nasdaq, a tech-heavy index, added 0.87%.

Coming into today, shares of the cannabis company had lost 11.75% in the past month. In that same time, the Finance sector lost 0.11%, while the S&P 500 gained 1.43%.

Investors will be hoping for strength from CRON as it approaches its next earnings release, which is expected to be February 27, 2020. The company is expected to report EPS of -$0.04, up 20% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $12.40 million, up 192.45% from the year-ago period.

Investors should also note any recent changes to analyst estimates for CRON. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

ADVERTISEMENT

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 2.82% higher. CRON currently has a Zacks Rank of #3 (Hold).

The Financial - Investment Management industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 15, which puts it in the top 6% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow CRON in the coming trading sessions, be sure to utilize Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research